tiprankstipranks
Inovio Pharmaceuticals (INO)
NASDAQ:INO
US Market
INO
Inovio Pharmaceuticals
RESEARCH TOOLSreports

Inovio Pharmaceuticals (INO) Income Statement

5,977 Followers

Inovio Pharmaceuticals Income Statement

Last quarter (Q4 2025), Inovio Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Inovio Pharmaceuticals's net income was $3.76M. See Inovio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 65.34K$ 217.76K$ 832.01K$ 10.26M$ 1.77M
Gross Profit
$ 65.34K$ 217.76K$ 832.01K$ 10.26M$ 1.77M
Operating Expenses
$ 86.89M$ 112.62M$ 144.77M$ 277.84M$ 302.99M
Depreciation and Amortization
$ 2.99M$ 3.13M$ 3.50M$ 5.50M$ 4.73M
EBITDA
$ -81.96M$ -103.95M$ -130.39M$ -270.90M$ -296.56M
Operating Income
$ -86.82M$ -112.40M$ -143.94M$ -267.57M$ -301.22M
Other Income/Expenses
$ 1.88M$ 5.14M$ 8.82M$ -12.24M$ -2.44M
Pretax Income
$ -84.95M$ -107.25M$ -135.12M$ -279.82M$ -303.66M
Net Income
$ -84.95M$ -107.25M$ -135.12M$ -279.82M$ -303.66M
Per Share Metrics
Basic EPS
$ -1.81$ -3.95$ -6.09$ -14.07$ -1.42
Diluted EPS
$ -1.81$ -3.95$ -6.09$ -14.07$ -1.42
Weighted Average Shares Outstanding
 468.86M 27.16M 22.17M 19.89M 214.62M
Weighted Average Shares Outstanding (Diluted)
 468.86M 27.16M 22.17M 19.89M 214.62M
Currency in USD

Inovio Pharmaceuticals Earnings and Revenue History